Foghorn Therapeutics broke ground in January of 2020 on its 60,000-sf headquarters in Cambridge, Mass. Located in Kendall Square, the facility will provide chemistry and biology labs, open offices, conference rooms, huddle rooms, and an employee café. Foghorn will occupy over three floors in the building, which is owned by Alexandria Real Estate Equities and managed by CBRE. Building Information Modeling (BIM) will be implemented in the delivery of the fast-track project, which will be constructed utilizing prefabricated mechanical systems. The facility was designed by TRIA and is being built by Wise Construction. The project team also includes engineering consultant R.W. Sullivan and code consultant Code Red Consultants. Completion is expected in late 2020.